Koers Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Aandelen
TEVA
IL0006290147
Farmaceutische producten
Omzet 2024 * | 15,86 mld. 60,24 mld. 14,81 mld. | Omzet 2025 * | 16,35 mld. 62,07 mld. 15,26 mld. | Marktkapitalisatie | 14,74 mld. 55,96 mld. 13,76 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,54 mld. 5,84 mld. 1,44 mld. | Nettowinst (verlies) 2025 * | 1,44 mld. 5,48 mld. 1,35 mld. | EV/omzet 2024 * | 1,85 x |
Nettoschuld 2024 * | 14,62 mld. 55,53 mld. 13,65 mld. | Nettoschuld 2025 * | 12,12 mld. 46,02 mld. 11,31 mld. | EV/omzet 2025 * | 1,64 x |
K/w-verhouding 2024 * |
10,4
x | K/w-verhouding 2025 * |
9,73
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 89,71% |
Recentste transcriptie over Teva Pharmaceutical Industries Limited
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01-01-23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22-12-19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01-09-15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09-06-20 |
Sol Barer
CHM | Chairman | 76 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,86% | 562 mld. | |
-6,34% | 358 mld. | |
+18,44% | 322 mld. | |
+7,39% | 297 mld. | |
+13,15% | 219 mld. | |
+6,08% | 199 mld. | |
-10,27% | 196 mld. | |
-10,96% | 149 mld. | |
-6,78% | 146 mld. |